Capparis spinosa reduces Doxorubicin-induced cardio-toxicity in cardiomyoblast cells

Objective: Doxorubicin (DOX) is an effective anticancer drug but its clinical application is limited because it induces apoptosis in cardiomyocytes and leads to permanent degenerative cardiomyopathy and heart failure possibly due to oxidative stress. Recent studies showed that Capparis spinosa (C. s...

Full description

Saved in:
Bibliographic Details
Main Authors: Seyed Hadi Mousavi (Author), Azar Hosseini (Author), Elham Bakhtiari (Author), Hassan Rakhshandeh (Author)
Format: Book
Published: Mashhad University of Medical Sciences, 2016-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c95e80a7c38e40f0ac6acad18fa4a42a
042 |a dc 
100 1 0 |a Seyed Hadi Mousavi  |e author 
700 1 0 |a Azar Hosseini  |e author 
700 1 0 |a Elham Bakhtiari  |e author 
700 1 0 |a Hassan Rakhshandeh  |e author 
245 0 0 |a Capparis spinosa reduces Doxorubicin-induced cardio-toxicity in cardiomyoblast cells 
260 |b Mashhad University of Medical Sciences,   |c 2016-08-01T00:00:00Z. 
500 |a 2228-7930 
500 |a 2228-7949 
520 |a Objective: Doxorubicin (DOX) is an effective anticancer drug but its clinical application is limited because it induces apoptosis in cardiomyocytes and leads to permanent degenerative cardiomyopathy and heart failure possibly due to oxidative stress. Recent studies showed that Capparis spinosa (C. spinose)exhibits potent antioxidant activity. So, in this study, we explored the protective effect of hydro-alcoholic extract of C. spinosa against DOX-induced cytotoxicity in H9c2 cells. Materials and Methods: Cell viability was quantified by MTT assay. Apoptotic cells were determined using flow cytometry (sub-G1 peak) evaluation of DNA fragmentation following PI staining. Cells were cultured with 5 μM DOX for 24 hr to induce cell damage. H9c2 cells were pretreated with different concentrations (6-200 μg/ml) of C. spinosa extract for 4 hr before DOX treatment in all trials. Results:  Pretreatment with 25, 50, 100 and 200 µg/ml of C. spinosa could increase the viability of H9C2 cells to 72.63 ± 2.8% (p< 0.05), 77.37 ± 1.8% (p< 0.05), 83.56 ± 2.6% (p< 0.001) and 90.9 ± 0.5% (p< 0.001) of control, respectively. Also, C. spinosa decreased apoptotic induction significantly, at the doses of 50 µg/ml (p 
546 |a EN 
690 |a Capparis spinosa 
690 |a H9C2 cells 
690 |a Doxorubicin 
690 |a Apoptosis 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Avicenna Journal of Phytomedicine, Vol 6, Iss 5, Pp 489-494 (2016) 
787 0 |n http://ajp.mums.ac.ir/article_6207_5919754ede89b380c54dcd95dff9ab9f.pdf 
787 0 |n https://doaj.org/toc/2228-7930 
787 0 |n https://doaj.org/toc/2228-7949 
856 4 1 |u https://doaj.org/article/c95e80a7c38e40f0ac6acad18fa4a42a  |z Connect to this object online.